Keyword :   systemic sclerosis

PROGRESSIVE PULMONARY FIBROSIS: THERAPEUTIC AND DIAGNOSTIC TACTICS AND A SINGLE TARGET DRUG
Author:Polyakova Daria №89–90 (3–4) 2022 / Review: 6
FEATURES OF SYSTEMIC SCLEROSIS INDUCTION IN EXPERIMENTAL CONDITIONS
Authors: Doskaliuk B.V. Zaiats L.M. Yatsyshyn R.I. №87 (1) 2022 / Review: 29
ERASMUS SYNDROME AS SILICON INDUCED FORM OF SYSTEMIC SCLEROSIS
Authors: Syniachenko O.V. Mikuksts V.Ya. Iermolaieva M.V. №74 (4) 2018 / Review: 20
RAYNAUD’S PHENOMENON AND DIGITAL ULCERS IN SYSTEMIC SCLEROSIS: PATHOPHYSIOLOGY QUESTIONS AND MANAGEMENT AT THE PRESENT STAGE
Authors: Golovach I.Yu. Chipko T.M. Korbut N.N. №70 (4) 2017 / Review: 4
Pulmonary arterial hypertension in patients with systemic sclerosis
Authors: Protsenko G.O. Sirenko Yu.M. №66 (4) 2016 / Review: 5
Risk of development and peculiarities of nefropathy in patients with systemic sclerosis
Authors: Kuryata O.V. Lysunets T.K. Karavanska I.L. Semenov V.V. №61 (3) 2015 / Review: 3
Clinical and pathogenetic VALUE of air conditioning, moisture exudation, surfactant changes and lungs diffusive CAPACITY changes in patients with systemic scleroSIS
Authors: Syniachenko O.V. Sovpel I.V. Milner I.A. Yurieva, A.V. Sovpel I.V. №46 (4) 2011 / Review: 4
SYSTEMIC SCLEROSIS AND ATHEROSCLEROSIS
Authors: Amosova K.M. Kovganich Т.А. Ter-Vartanіan S.Kh. Makomela N.M.... №27 (1) 2007 г. / Review: 11
THE ROLE AN INTERFERON-GAMMA IN A PATHOGENY OF A SYSTEM SCLERODERMA
Authors: Neyko Ye.M. Yatsyshyn R.I. Yatsyshyn M.I. Balan U.V. №11 2003г. / Review: 36
THE INFLUENCE TOCOPHEROL AND CAPTOPRIL ON PEROXYDATIVE LIPID OXIDATION AND RENIN-ANGIOTENSIN SYSTEM IN SCLERODERMA PATIENTS O.V. Lukovska
Author:Lukovska O.V. PATIENTS SCLERODERMA IN SYSTEM RENIN-ANGIOTENSIN AND OXIDATION LIPID PEROXYDATIVE ON CAPTOPRIL AND TOCOPHEROL INFLUENCE THE №7 2002г. / Review: 30